Trial · NCT05103332
Results by group216
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 216
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Indapamide: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data | DB Period: Placebo (Add-on to Indapamide) | -3.7 | Standard Error 1.56 | mmHg | |
| Indapamide: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data | DB Period: Zilebesiran (Add-on to Indapamide) | -15.7 | Standard Error 1.60 | mmHg | |
| Amlodipine: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data | DB Period: Placebo (Add-on to Amlodipine) | -0.7 | Standard Error 1.14 | mmHg | |
| Amlodipine: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data | DB Period: Zilebesiran (Add-on to Amlodipine) | -10.5 | Standard Error 1.15 | mmHg | |
| Olmesartan: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data | DB Period: Placebo (Add-on to Olmesartan) | -3.2 | Standard Error 1.34 | mmHg | |
| Olmesartan: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data | DB Period: Zilebesiran (Add-on to Olmesartan) | -7.7 | Standard Error 1.33 | mmHg | |
| Indapamide: Change From Baseline at Month 3 in Office SBP - Censored Data | DB Period: Placebo (Add-on to Indapamide) | -0.8 | Standard Error 1.55 | mmHg | |
| Indapamide: Change From Baseline at Month 3 in Office SBP - Censored Data | DB Period: Zilebesiran (Add-on to Indapamide) | -19.3 | Standard Error 1.52 | mmHg | |
| Indapamide: Time-adjusted Change From Baseline Through Month 6 in 24-hour Mean SBP, Assessed by ABPM - All Collected Data | DB Period: Placebo (Add-on to Indapamide) | -4.6 | Standard Error 1.30 | mmHg | |
| Indapamide: Time-adjusted Change From Baseline Through Month 6 in 24-hour Mean SBP, Assessed by ABPM - All Collected Data | DB Period: Zilebesiran (Add-on to Indapamide) | -15.6 | Standard Error 1.35 | mmHg | |
| Indapamide: Time-adjusted Change From Baseline Through Month 6 in Office SBP - All Collected Data | DB Period: Placebo (Add-on to Indapamide) | -4.5 | Standard Error 1.16 | mmHg | |
| Indapamide: Time-adjusted Change From Baseline Through Month 6 in Office SBP - All Collected Data | DB Period: Zilebesiran (Add-on to Indapamide) | -18.1 | Standard Error 1.18 | mmHg | |
| Indapamide: Percentage of Participants With 24-hour Mean SBP <130 mmHg and/or Reduction From Baseline ≥20 mmHg Assessed by ABPM Without Escape Antihypertensive Medications at Month 6 | DB Period: Placebo (Add-on to Indapamide) | 14.0 | percentage of participants | ||
| Indapamide: Percentage of Participants With 24-hour Mean SBP <130 mmHg and/or Reduction From Baseline ≥20 mmHg Assessed by ABPM Without Escape Antihypertensive Medications at Month 6 | DB Period: Zilebesiran (Add-on to Indapamide) | 64.2 | percentage of participants | ||
| Indapamide: Change From Baseline at Month 3 in 24-hour Mean Diastolic Blood Pressure (DBP), Assessed by ABPM - Censored Data | DB Period: Placebo (Add-on to Indapamide) | -1.3 | Standard Error 0.87 | mmHg | |
| Indapamide: Change From Baseline at Month 3 in 24-hour Mean Diastolic Blood Pressure (DBP), Assessed by ABPM - Censored Data | DB Period: Zilebesiran (Add-on to Indapamide) | -9.1 | Standard Error 0.89 | mmHg | |
| Indapamide: Change From Baseline at Month 3 in Office DBP - Censored Data | DB Period: Placebo (Add-on to Indapamide) | -0.2 | Standard Error 1.03 | mmHg | |
| Indapamide: Change From Baseline at Month 3 in Office DBP - Censored Data | DB Period: Zilebesiran (Add-on to Indapamide) | -10.5 | Standard Error 1.01 | mmHg | |
| Indapamide: Time-adjusted Change From Baseline Through Month 3 in 24-hour Mean SBP and DBP, Assessed by ABPM - Censored Data | DB Period: Placebo (Add-on to Indapamide) | 24-hour Mean SBP | -2.5 | Standard Error 1.22 | mmHg |
| Indapamide: Time-adjusted Change From Baseline Through Month 3 in 24-hour Mean SBP and DBP, Assessed by ABPM - Censored Data | DB Period: Zilebesiran (Add-on to Indapamide) | 24-hour Mean SBP | -15.4 | Standard Error 1.26 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05103332/results